After years of anticipation, all of the nation's drug and medical device makers must soon begin publicly reporting payments they make to U.S. physicians, according to final regulations announced this afternoon by the federal government. The release of payments data in September 2014 would mark a milestone in the push to bring transparency to medicine.
